Loading clinical trials...
Loading clinical trials...
Open-label, Multicenter, Single Arm, Phase III Study to Collect Additional Safety and Efficacy Data With Deferasirox Film-coated Tablets in Patients Completing Study CICL670F2201
Conditions
Interventions
Deferasirox
Locations
14
Austria
Novartis Investigative Site
Vienna, Austria
Novartis Investigative Site
Goudi-Athens, GR, Greece
Novartis Investigative Site
Pátrai, Greece
Novartis Investigative Site
Thessaloniki, Greece
Novartis Investigative Site
Catania, CT, Italy
Novartis Investigative Site
Cona, FE, Italy
Start Date
August 16, 2016
Primary Completion Date
July 23, 2019
Completion Date
July 23, 2019
Last Updated
March 3, 2020
NCT06215287
NCT05440487
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions